We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

13 hedge funds and large institutions have $161K invested in HCW Biologics in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 13 → 13 (0)

0.56% less ownership

Funds ownership: 2.7% → 2.13% (-0.56%)

62% less capital invested

Capital invested by funds: $424K → $161K (-$263K)

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$230K
2
VF
Virtu Financial
New York
+$41.2K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$18.8K
4
Jane Street
Jane Street
New York
+$12.2K
5
Citigroup
Citigroup
New York
+$9.07K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$291K
2
DS
DRW Securities
Illinois
-$34.2K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19.5K
4
JWCA
J.W. Cole Advisors
Florida
-$12.1K
5
Bank of America
Bank of America
North Carolina
-$11
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
1
HRT Financial
New York
$95K +$230K +44,399 New
VF
2
Virtu Financial
New York
$17K +$41.2K +7,968 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$12.9K +$18.8K +3,641 +156%
Citadel Advisors
4
Citadel Advisors
Florida
$9.39K +$3.38K +654 +18%
TRCT
5
Tower Research Capital (TRC)
New York
$5.34K +$8.9K +1,722 +229%
Jane Street
6
Jane Street
New York
$5.09K +$12.2K +2,356 New
VCM
7
Vanguard Capital Management
Pennsylvania
$4.33K +$10.4K +2,004 New
Citigroup
8
Citigroup
New York
$3.79K +$9.07K +1,755 New
GSWM
9
Golden State Wealth Management
California
$3.6K – – –
UBS Group
10
UBS Group
Switzerland
$3.32K +$6.45K +1,247 +430%
VFT
11
Vanguard Fiduciary Trust
Pennsylvania
$685 +$1.64K +317 New
Wells Fargo
12
Wells Fargo
California
$360 – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$9 – – –
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$1 – – –
AC
15
Armistice Capital
New York
– -$291K -50,030 Closed
DS
16
DRW Securities
Illinois
– -$34.2K -5,880 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$19.5K -3,345 Closed
JWCA
18
J.W. Cole Advisors
Florida
– -$12.1K -2,083 Closed
Bank of America
19
Bank of America
North Carolina
– -$11 -2 Closed

HCWB Hedge Fund Activity: Q1 2026 in Review

13 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q1 2026, worth a combined $161K — down 62% from $424K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HCWB positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $230K. The largest seller was Armistice Capital, exiting entirely with an estimated $291K sold.

  • 13 institutional investors held HCW Biologics (HCWB) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $161K of HCW Biologics stock for Q1 2026, down 62% quarter-over-quarter.
  • 6 funds opened new HCW Biologics positions in Q1 2026 and 5 closed out, a net change of +1 holder.
  • The largest HCW Biologics buyer in Q1 2026 was HRT Financial, an estimated $230K added.
  • The largest HCW Biologics seller in Q1 2026 was Armistice Capital, an estimated $291K sold.

Based on aggregated 13F filings for Q1 2026.